{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:30:18Z","timestamp":1757619018740,"version":"3.44.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04126-0","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:23:08Z","timestamp":1752679388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interferon therapy for chronic hepatitis B virus infection affects nucleoside metabolism: a metabolomics study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiangyang","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengfeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanbing","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"10381","key":"4126_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF. Hepat B Lancet. 2023;401(10381):1039\u201352.","journal-title":"Hepat B Lancet"},{"key":"4126_CR2","doi-asserted-by":"crossref","unstructured":"Jeng WJ, Lok ASF. What will it take to cure hepatitis B? Hepatol Commun. 2023;7(4):e0084.","DOI":"10.1097\/HC9.0000000000000084"},{"key":"4126_CR3","doi-asserted-by":"crossref","unstructured":"Nishio A, et al. Clearance of pegylated interferon by Kupffer cells limits NK cell activation and therapy response of patients with HBV infection. Sci Transl Med. 2021;13(587):eaba6322.","DOI":"10.1126\/scitranslmed.aba6322"},{"issue":"2","key":"4126_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.31282","volume":"73","author":"J Chen","year":"2021","unstructured":"Chen J, et al. Functional comparison of Interferon-alpha subtypes reveals potent hepatitis B virus suppression by a concerted action of Interferon-alpha and Interferon-gamma signaling. Hepatology. 2021;73(2):486\u2013502.","journal-title":"Hepatology"},{"issue":"6176","key":"4126_CR5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.1243462","volume":"343","author":"J Lucifora","year":"2014","unstructured":"Lucifora J, et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus CccDNA. Science. 2014;343(6176):1221\u20138.","journal-title":"Science"},{"issue":"1","key":"4126_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00535-021-01840-w","volume":"57","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. T follicular helper cells improve the response of patients with chronic hepatitis B to interferon by promoting HBsAb production. J Gastroenterol. 2022;57(1):30\u201345.","journal-title":"J Gastroenterol"},{"key":"4126_CR7","doi-asserted-by":"publisher","first-page":"105782","DOI":"10.1016\/j.antiviral.2023.105782","volume":"221","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, et al. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy. Antiviral Res. 2024;221:105782.","journal-title":"Antiviral Res"},{"issue":"1","key":"4126_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/HEP.0000000000000524","volume":"79","author":"P Jiang","year":"2024","unstructured":"Jiang P, et al. Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-alpha in patients with chronic hepatitis B. Hepatology. 2024;79(1):167\u201382.","journal-title":"Hepatology"},{"issue":"4","key":"4126_CR9","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/S2352-3026(17)30030-3","volume":"4","author":"L Masarova","year":"2017","unstructured":"Masarova L, et al. Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial. Lancet Haematol. 2017;4(4):e165\u201375.","journal-title":"Lancet Haematol"},{"issue":"1","key":"4126_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2022;22(1):19\u201332.","journal-title":"Nat Rev Immunol"},{"key":"4126_CR11","doi-asserted-by":"publisher","first-page":"1189417","DOI":"10.3389\/fcimb.2023.1189417","volume":"13","author":"J Yang","year":"2023","unstructured":"Yang J, et al. Metabolomics in viral hepatitis: advances and review. Front Cell Infect Microbiol. 2023;13:1189417.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"4126_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11306-020-01767-y","volume":"17","author":"HTT Nguyen","year":"2021","unstructured":"Nguyen HTT, et al. Metabolic fingerprint of progression of chronic hepatitis B: changes in the metabolome and novel diagnostic possibilities. Metabolomics. 2021;17(2):16.","journal-title":"Metabolomics"},{"key":"4126_CR13","doi-asserted-by":"crossref","unstructured":"Pu W, et al. Dysregulation of lipid metabolism in the pseudolobule promotes region-specific autophagy in hepatitis B liver cirrhosis. Hepatol Commun. 2023;7(8):e0187.","DOI":"10.1097\/HC9.0000000000000187"},{"issue":"4","key":"4126_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.14218\/JCTH.2016.00019","volume":"5","author":"J Hou","year":"2017","unstructured":"Hou J, et al. Guideline of prevention and treatment for chronic hepatitis B (2015 Update). J Clin Transl Hepatol. 2017;5(4):297\u2013318.","journal-title":"J Clin Transl Hepatol"},{"issue":"15","key":"4126_CR15","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.1007\/s00216-013-6927-9","volume":"405","author":"H Bi","year":"2013","unstructured":"Bi H, et al. Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells. Anal Bioanal Chem. 2013;405(15):5279\u201389.","journal-title":"Anal Bioanal Chem"},{"key":"4126_CR16","doi-asserted-by":"crossref","unstructured":"Thurm C, Schraven B, Kahlfuss S. ABC transporters in T Cell-Mediated physiological and pathological immune responses. Int J Mol Sci. 2021;22(17):9186.","DOI":"10.3390\/ijms22179186"},{"issue":"3","key":"4126_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1096\/fasebj.14.3.516","volume":"14","author":"CG Lee","year":"2000","unstructured":"Lee CG, et al. Effect of ABC transporters on HIV-1 infection: Inhibition of virus production by the MDR1 transporter. FASEB J. 2000;14(3):516\u201322.","journal-title":"FASEB J"},{"key":"4126_CR18","doi-asserted-by":"crossref","unstructured":"Drozdzik M, et al. Protein abundance of drug transporters in human hepatitis C livers. Int J Mol Sci. 2022;23(14):7947.","DOI":"10.3390\/ijms23147947"},{"issue":"1","key":"4126_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s13071-020-04294-w","volume":"13","author":"MJ Li","year":"2020","unstructured":"Li MJ, et al. Transcriptome analysis of Aedes aegypti Aag2 cells in response to dengue virus-2 infection. Parasit Vectors. 2020;13(1):421.","journal-title":"Parasit Vectors"},{"issue":"12","key":"4126_CR20","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1517\/17425250903304056","volume":"5","author":"O Fardel","year":"2009","unstructured":"Fardel O, Vee ML. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines. Expert Opin Drug Metab Toxicol. 2009;5(12):1469\u201381.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4126_CR21","doi-asserted-by":"crossref","unstructured":"Chen ML, et al. Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes. J Exp Med. 2020;217(5):e20191388.","DOI":"10.1084\/jem.20191388"},{"key":"4126_CR22","first-page":"834060","volume":"2010","author":"D Echeverri","year":"2010","unstructured":"Echeverri D, et al. Caffeine\u2019s vascular mechanisms of action. Int J Vasc Med. 2010;2010:834060.","journal-title":"Int J Vasc Med"},{"key":"4126_CR23","doi-asserted-by":"crossref","unstructured":"Romero-Martinez BS, et al. Possible beneficial actions of caffeine in SARS-CoV-2. Int J Mol Sci. 2021;22(11):5460.","DOI":"10.3390\/ijms22115460"},{"issue":"4","key":"4126_CR24","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1128\/JVI.79.4.2058-2065.2005","volume":"79","author":"R Daniel","year":"2005","unstructured":"Daniel R, et al. Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells. J Virol. 2005;79(4):2058\u201365.","journal-title":"J Virol"},{"issue":"3","key":"4126_CR25","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.clnu.2022.01.016","volume":"41","author":"T Barre","year":"2022","unstructured":"Barre T, et al. Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 hepather cohort). Clin Nutr. 2022;41(3):610\u20139.","journal-title":"Clin Nutr"},{"issue":"2","key":"4126_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1124\/pr.117.014407","volume":"70","author":"A Nehlig","year":"2018","unstructured":"Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018;70(2):384\u2013411.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"4126_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMra1816604","volume":"383","author":"RM van Dam","year":"2020","unstructured":"van Dam RM, Hu FB, Willett WC. Coffee, caffeine, and health. N Engl J Med. 2020;383(4):369\u201378.","journal-title":"N Engl J Med"},{"issue":"3","key":"4126_CR28","doi-asserted-by":"publisher","first-page":"e1576","DOI":"10.1002\/wrna.1576","volume":"11","author":"R Netzband","year":"2020","unstructured":"Netzband R, Pager CT. Epitranscriptomic marks: emerging modulators of RNA virus gene expression. Wiley Interdiscip Rev RNA. 2020;11(3):e1576.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"11","key":"4126_CR29","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1093\/nar\/gky029","volume":"46","author":"W McIntyre","year":"2018","unstructured":"McIntyre W, et al. Positive-sense RNA viruses reveal the complexity and dynamics of the cellular and viral epitranscriptomes during infection. Nucleic Acids Res. 2018;46(11):5776\u201391.","journal-title":"Nucleic Acids Res"},{"key":"4126_CR30","doi-asserted-by":"publisher","first-page":"845625","DOI":"10.3389\/fmicb.2022.845625","volume":"13","author":"J Tong","year":"2022","unstructured":"Tong J, et al. The emerging role of RNA modifications in the regulation of antiviral innate immunity. Front Microbiol. 2022;13:845625.","journal-title":"Front Microbiol"},{"issue":"2","key":"4126_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ni.1979","volume":"12","author":"R Zust","year":"2011","unstructured":"Zust R, et al. Ribose 2\u2019-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol. 2011;12(2):137\u201343.","journal-title":"Nat Immunol"},{"key":"4126_CR32","doi-asserted-by":"crossref","unstructured":"Tong J, et al. Pooled CRISPR screening identifies m(6)A as a positive regulator of macrophage activation. Sci Adv. 2021;7(18):eabd4742.","DOI":"10.1126\/sciadv.abd4742"},{"issue":"3","key":"4126_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.molcel.2019.11.007","volume":"77","author":"NS Gokhale","year":"2020","unstructured":"Gokhale NS, et al. Altered m(6)A modification of specific cellular transcripts affects flaviviridae infection. Mol Cell. 2020;77(3):542\u2013e5558.","journal-title":"Mol Cell"},{"issue":"2","key":"4126_CR34","doi-asserted-by":"publisher","first-page":"e1008338","DOI":"10.1371\/journal.ppat.1008338","volume":"16","author":"H Imam","year":"2020","unstructured":"Imam H, et al. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified hepatitis B virus transcripts. PLoS Pathog. 2020;16(2):e1008338.","journal-title":"PLoS Pathog"},{"issue":"35","key":"4126_CR35","doi-asserted-by":"publisher","first-page":"8829","DOI":"10.1073\/pnas.1808319115","volume":"115","author":"H Imam","year":"2018","unstructured":"Imam H, et al. N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle. Proc Natl Acad Sci U S A. 2018;115(35):8829\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4126_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.medj.2024.01.010","volume":"5","author":"AJ Tessier","year":"2024","unstructured":"Tessier AJ, et al. Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: four prospective US cohort studies. Med. 2024;5(3):224\u201338. e5.","journal-title":"Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04126-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:43:20Z","timestamp":1757249000000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04126-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4126"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04126-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Ethics Committee of the Affiliated Hospital of Putian University and carried out in accordance with the Helsinki Declaration. All the participants were informed, and written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"523"}}